Global Dignostics Rapid Test Kits Market
Global Dignostics Rapid Test Kits Market

Dignostics Rapid Test Kits Comprehensive Study by Type (Over-The-Counter (OTC) Kits, Professional Kits), Application (Blood Glucose Testing, Infectious Disease Testing, Cardiometabolic Testing, Pregnancy and Fertility Testing, Fecal Occult Blood Testing, Coagulation Testing, Toxicology Testing, Lipid Profile Testing), End-Use (Hospitals & Clinics, Home Care, Diagnostic Laboratories), Sample Type (Blood Sample, Urine Sample)

Dignostics Rapid Test Kits Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Sep 2020 Edition 226 Pages 214 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Dignostics Rapid Test Kits Market Overview:
Diagnostic Rapid test kits help in the rapid etiological diagnosis of various chronic diseases. These test kits are easy to use and require limited training to enable effective analysis. The target audience in the market is the general population suffering from chronic diseases. The proliferation of chronic diseases such as cancer, infectious diseases, and diabetes should drive the growth of the rapid medical diagnostic kit market. The growing need for and awareness of rapid chronic disease detection should also encourage acceptance of these medical kits. In addition, these rapid diagnostic test kits are one of the most important ones during this time of the virus outbreak. This consumes a large amount of market share in both the present and the future. Some of the key players profiled in the study are Siemens AG (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories (United States), Danaher Corporation (United States), Thermo-Fisher Scientific Inc. (United States), Merck KGaA (Germany), Becton, Dickinson, and Company (United States), Hologic, Inc. (United States), Alere Inc. (United States) and Bio-Rad Laboratories (United States).

On the basis of geography, the market of Dignostics Rapid Test Kits has been segmented into . If we see Market by End-Use, the sub-segment i.e. Hospitals & Clinics will boost the Dignostics Rapid Test Kits market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Sample Type , the sub-segment i.e. Blood Sample will boost the Dignostics Rapid Test Kits market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • The Rising Outbreak of Novel Coronavirus has made the market to grow at its full speed
  • Increasing Prevalence of Chronic Diseases

Market Trend
  • Adoption of Over the Counter Test (OTC) Kits Across the Globe
  • Acceptance of new Technologies in these Kits

Restraints
  • Stringent Government Policies about these Kits
  • Lack of Awareness Regarding Newer Rapid Diagnostic Tests

Opportunities
  • Cumulating Number of Hospital that uses these Test Kits
  • Increasing Number of Laboratory to check Various Diseases

Challenges
  • High Cost Associated With These Test Kits
  • Absence of Mindfulness in Regards to Fresher Quick Symptomatic Tests Combined with the Inability to Dispose of the Requirement for Microscopy Conclusion May Control the Development of the Market During the Given Time Span


Major Market Developments:


According to WHO, The recent facts about the usage of rapid diagnostic test kits till 3 Sept 2020, is 26,177,603 cases, with the same number of diagnostic test kits used across the globe. Hence rising the market for many manufactures of the Diagnostic rapid test kits market.
Government bodies are additionally contributing vigorously to check the high predominance of different irresistible sicknesses, for example, jungle fever and the novel COVID. For example, according to WHO, in 2017, government specialists and private worldwide speculators of endemic countries contributed around USD 3.1 billion to control and dispose of the ailment. In March 2020, Mesa Biotech, Inc., a U.S based sub-atomic indicative organization, gotten USD 561,000 agreement from the U.S. Division of Health and Human Services (HHS) for the advancement of a novel fast sub-atomic analytic test packs for COVID-19.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.

Target Audience:
Manufacturers, Suppliers, Wholesalers, Distributors, and Retailers, End-User and Governmental bodies

Major Objectives Focused through this Study
• To define, describe, and forecast the Global Dignostics Rapid Test Kits market on the basis of product [Over-The-Counter (OTC) Kits and Professional Kits] , application [Blood Glucose Testing, Infectious Disease Testing, Cardiometabolic Testing, Pregnancy and Fertility Testing, Fecal Occult Blood Testing, Coagulation Testing, Toxicology Testing and Lipid Profile Testing], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Dignostics Rapid Test Kits market with respect to major geographies, namely,
• To strategically profile the key players and analyzing their market shares and core competencies in the Dignostics Rapid Test Kits industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are bioMérieux (France) and BD (United States).
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Dignostics Rapid Test Kits market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.
Report Objectives / Segmentation Covered
By Type
  • Over-The-Counter (OTC) Kits
  • Professional Kits
By Application
  • Blood Glucose Testing
  • Infectious Disease Testing
  • Cardiometabolic Testing
  • Pregnancy and Fertility Testing
  • Fecal Occult Blood Testing
  • Coagulation Testing
  • Toxicology Testing
  • Lipid Profile Testing
By End-Use
  • Hospitals & Clinics
  • Home Care
  • Diagnostic Laboratories

By Sample Type
  • Blood Sample
  • Urine Sample

By Regions
    • 1. Market Overview
      • 1.1. Introduction
      • 1.2. Scope/Objective of the Study
        • 1.2.1. Research Objective
    • 2. Executive Summary
      • 2.1. Introduction
    • 3. Market Dynamics
      • 3.1. Introduction
      • 3.2. Market Drivers
        • 3.2.1. The Rising Outbreak of Novel Coronavirus has made the market to grow at its full speed
        • 3.2.2. Increasing Prevalence of Chronic Diseases
      • 3.3. Market Challenges
        • 3.3.1. High Cost Associated With These Test Kits
        • 3.3.2. Absence of Mindfulness in Regards to Fresher Quick Symptomatic Tests Combined with the Inability to Dispose of the Requirement for Microscopy Conclusion May Control the Development of the Market During the Given Time Span
      • 3.4. Market Trends
        • 3.4.1. Adoption of Over the Counter Test (OTC) Kits Across the Globe
        • 3.4.2. Acceptance of new Technologies in these Kits
    • 4. Market Factor Analysis
      • 4.1. Porters Five Forces
      • 4.2. Supply/Value Chain
      • 4.3. PESTEL analysis
      • 4.4. Market Entropy
      • 4.5. Patent/Trademark Analysis
    • 5. Global Dignostics Rapid Test Kits, by Type, Application, End-Use and Sample Type (value, volume and price ) (2014-2019)
      • 5.1. Introduction
      • 5.2. Global Dignostics Rapid Test Kits (Value)
        • 5.2.1. Global Dignostics Rapid Test Kits by: Type (Value)
          • 5.2.1.1. Over-The-Counter (OTC) Kits
          • 5.2.1.2. Professional Kits
        • 5.2.2. Global Dignostics Rapid Test Kits by: Application (Value)
          • 5.2.2.1. Blood Glucose Testing
          • 5.2.2.2. Infectious Disease Testing
          • 5.2.2.3. Cardiometabolic Testing
          • 5.2.2.4. Pregnancy and Fertility Testing
          • 5.2.2.5. Fecal Occult Blood Testing
          • 5.2.2.6. Coagulation Testing
          • 5.2.2.7. Toxicology Testing
          • 5.2.2.8. Lipid Profile Testing
        • 5.2.3. Global Dignostics Rapid Test Kits by: End-Use (Value)
          • 5.2.3.1. Hospitals & Clinics
          • 5.2.3.2. Home Care
          • 5.2.3.3. Diagnostic Laboratories
      • 5.3. Global Dignostics Rapid Test Kits (Volume)
        • 5.3.1. Global Dignostics Rapid Test Kits by: Type (Volume)
          • 5.3.1.1. Over-The-Counter (OTC) Kits
          • 5.3.1.2. Professional Kits
        • 5.3.2. Global Dignostics Rapid Test Kits by: Application (Volume)
          • 5.3.2.1. Blood Glucose Testing
          • 5.3.2.2. Infectious Disease Testing
          • 5.3.2.3. Cardiometabolic Testing
          • 5.3.2.4. Pregnancy and Fertility Testing
          • 5.3.2.5. Fecal Occult Blood Testing
          • 5.3.2.6. Coagulation Testing
          • 5.3.2.7. Toxicology Testing
          • 5.3.2.8. Lipid Profile Testing
        • 5.3.3. Global Dignostics Rapid Test Kits by: End-Use (Volume)
          • 5.3.3.1. Hospitals & Clinics
          • 5.3.3.2. Home Care
          • 5.3.3.3. Diagnostic Laboratories
      • 5.4. Global Dignostics Rapid Test Kits (Price)
        • 5.4.1. Global Dignostics Rapid Test Kits by: Type (Price)
    • 6. Dignostics Rapid Test Kits: Manufacturers/Players Analysis
      • 6.1. Competitive Landscape
        • 6.1.1. Market Share Analysis
          • 6.1.1.1. Top 3
          • 6.1.1.2. Top 5
      • 6.2. Peer Group Analysis (2019)
      • 6.3. BCG Matrix
      • 6.4. Company Profile
        • 6.4.1. Siemens AG (Germany)
          • 6.4.1.1. Business Overview
          • 6.4.1.2. Products/Services Offerings
          • 6.4.1.3. Financial Analysis
          • 6.4.1.4. SWOT Analysis
        • 6.4.2. Roche Diagnostics (Switzerland)
          • 6.4.2.1. Business Overview
          • 6.4.2.2. Products/Services Offerings
          • 6.4.2.3. Financial Analysis
          • 6.4.2.4. SWOT Analysis
        • 6.4.3. Abbott Laboratories (United States)
          • 6.4.3.1. Business Overview
          • 6.4.3.2. Products/Services Offerings
          • 6.4.3.3. Financial Analysis
          • 6.4.3.4. SWOT Analysis
        • 6.4.4. Danaher Corporation (United States)
          • 6.4.4.1. Business Overview
          • 6.4.4.2. Products/Services Offerings
          • 6.4.4.3. Financial Analysis
          • 6.4.4.4. SWOT Analysis
        • 6.4.5. Thermo-Fisher Scientific Inc. (United States)
          • 6.4.5.1. Business Overview
          • 6.4.5.2. Products/Services Offerings
          • 6.4.5.3. Financial Analysis
          • 6.4.5.4. SWOT Analysis
        • 6.4.6. Merck KGaA (Germany)
          • 6.4.6.1. Business Overview
          • 6.4.6.2. Products/Services Offerings
          • 6.4.6.3. Financial Analysis
          • 6.4.6.4. SWOT Analysis
        • 6.4.7. Becton, Dickinson, and Company (United States)
          • 6.4.7.1. Business Overview
          • 6.4.7.2. Products/Services Offerings
          • 6.4.7.3. Financial Analysis
          • 6.4.7.4. SWOT Analysis
        • 6.4.8. Hologic, Inc. (United States)
          • 6.4.8.1. Business Overview
          • 6.4.8.2. Products/Services Offerings
          • 6.4.8.3. Financial Analysis
          • 6.4.8.4. SWOT Analysis
        • 6.4.9. Alere Inc. (United States)
          • 6.4.9.1. Business Overview
          • 6.4.9.2. Products/Services Offerings
          • 6.4.9.3. Financial Analysis
          • 6.4.9.4. SWOT Analysis
        • 6.4.10. Bio-Rad Laboratories (United States)
          • 6.4.10.1. Business Overview
          • 6.4.10.2. Products/Services Offerings
          • 6.4.10.3. Financial Analysis
          • 6.4.10.4. SWOT Analysis
    • 7. Global Dignostics Rapid Test Kits Sale, by Type, Application, End-Use and Sample Type (value, volume and price ) (2020-2025)
      • 7.1. Introduction
      • 7.2. Global Dignostics Rapid Test Kits (Value)
        • 7.2.1. Global Dignostics Rapid Test Kits by: Type (Value)
          • 7.2.1.1. Over-The-Counter (OTC) Kits
          • 7.2.1.2. Professional Kits
        • 7.2.2. Global Dignostics Rapid Test Kits by: Application (Value)
          • 7.2.2.1. Blood Glucose Testing
          • 7.2.2.2. Infectious Disease Testing
          • 7.2.2.3. Cardiometabolic Testing
          • 7.2.2.4. Pregnancy and Fertility Testing
          • 7.2.2.5. Fecal Occult Blood Testing
          • 7.2.2.6. Coagulation Testing
          • 7.2.2.7. Toxicology Testing
          • 7.2.2.8. Lipid Profile Testing
        • 7.2.3. Global Dignostics Rapid Test Kits by: End-Use (Value)
          • 7.2.3.1. Hospitals & Clinics
          • 7.2.3.2. Home Care
          • 7.2.3.3. Diagnostic Laboratories
      • 7.3. Global Dignostics Rapid Test Kits (Volume)
        • 7.3.1. Global Dignostics Rapid Test Kits by: Type (Volume)
          • 7.3.1.1. Over-The-Counter (OTC) Kits
          • 7.3.1.2. Professional Kits
        • 7.3.2. Global Dignostics Rapid Test Kits by: Application (Volume)
          • 7.3.2.1. Blood Glucose Testing
          • 7.3.2.2. Infectious Disease Testing
          • 7.3.2.3. Cardiometabolic Testing
          • 7.3.2.4. Pregnancy and Fertility Testing
          • 7.3.2.5. Fecal Occult Blood Testing
          • 7.3.2.6. Coagulation Testing
          • 7.3.2.7. Toxicology Testing
          • 7.3.2.8. Lipid Profile Testing
        • 7.3.3. Global Dignostics Rapid Test Kits by: End-Use (Volume)
          • 7.3.3.1. Hospitals & Clinics
          • 7.3.3.2. Home Care
          • 7.3.3.3. Diagnostic Laboratories
      • 7.4. Global Dignostics Rapid Test Kits (Price)
        • 7.4.1. Global Dignostics Rapid Test Kits by: Type (Price)
    • 8. Appendix
      • 8.1. Acronyms
    • 9. Methodology and Data Source
      • 9.1. Methodology/Research Approach
        • 9.1.1. Research Programs/Design
        • 9.1.2. Market Size Estimation
        • 9.1.3. Market Breakdown and Data Triangulation
      • 9.2. Data Source
        • 9.2.1. Secondary Sources
        • 9.2.2. Primary Sources
      • 9.3. Disclaimer
    List of Tables
    • Table 1. Dignostics Rapid Test Kits: by Type(USD Million)
    • Table 2. Dignostics Rapid Test Kits: by Application(USD Million)
    • Table 3. Dignostics Rapid Test Kits: by End-Use(USD Million)
    • Table 4. Dignostics Rapid Test Kits Sales: by Type(K Units)
    • Table 5. Dignostics Rapid Test Kits Sales: by Application(K Units)
    • Table 6. Dignostics Rapid Test Kits Sales: by End-Use(K Units)
    • Table 7. Dignostics Rapid Test Kits: by Type(USD/Units)
    • Table 8. Company Basic Information, Sales Area and Its Competitors
    • Table 9. Company Basic Information, Sales Area and Its Competitors
    • Table 10. Company Basic Information, Sales Area and Its Competitors
    • Table 11. Company Basic Information, Sales Area and Its Competitors
    • Table 12. Company Basic Information, Sales Area and Its Competitors
    • Table 13. Company Basic Information, Sales Area and Its Competitors
    • Table 14. Company Basic Information, Sales Area and Its Competitors
    • Table 15. Company Basic Information, Sales Area and Its Competitors
    • Table 16. Company Basic Information, Sales Area and Its Competitors
    • Table 17. Company Basic Information, Sales Area and Its Competitors
    • Table 18. Dignostics Rapid Test Kits: by Type(USD Million)
    • Table 19. Dignostics Rapid Test Kits: by Application(USD Million)
    • Table 20. Dignostics Rapid Test Kits: by End-Use(USD Million)
    • Table 21. Dignostics Rapid Test Kits Sales: by Type(K Units)
    • Table 22. Dignostics Rapid Test Kits Sales: by Application(K Units)
    • Table 23. Dignostics Rapid Test Kits Sales: by End-Use(K Units)
    • Table 24. Dignostics Rapid Test Kits: by Type(USD/Units)
    • Table 25. Research Programs/Design for This Report
    • Table 26. Key Data Information from Secondary Sources
    • Table 27. Key Data Information from Primary Sources
    List of Figures
    • Figure 1. Porters Five Forces
    • Figure 2. Supply/Value Chain
    • Figure 3. PESTEL analysis
    • Figure 4. Global Dignostics Rapid Test Kits: by Type USD Million (2014-2019)
    • Figure 5. Global Dignostics Rapid Test Kits: by Application USD Million (2014-2019)
    • Figure 6. Global Dignostics Rapid Test Kits: by End-Use USD Million (2014-2019)
    • Figure 7. Global Dignostics Rapid Test Kits: by Type K Units (2014-2019)
    • Figure 8. Global Dignostics Rapid Test Kits: by Application K Units (2014-2019)
    • Figure 9. Global Dignostics Rapid Test Kits: by End-Use K Units (2014-2019)
    • Figure 10. Global Dignostics Rapid Test Kits: by Type USD/Units (2014-2019)
    • Figure 11. Global Dignostics Rapid Test Kits share by Players 2019 (%)
    • Figure 12. Global Dignostics Rapid Test Kits share by Players (Top 3) 2019(%)
    • Figure 13. Global Dignostics Rapid Test Kits share by Players (Top 5) 2019(%)
    • Figure 14. BCG Matrix for key Companies
    • Figure 15. Siemens AG (Germany) Revenue, Net Income and Gross profit
    • Figure 16. Siemens AG (Germany) Revenue: by Geography 2019
    • Figure 17. Roche Diagnostics (Switzerland) Revenue, Net Income and Gross profit
    • Figure 18. Roche Diagnostics (Switzerland) Revenue: by Geography 2019
    • Figure 19. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
    • Figure 20. Abbott Laboratories (United States) Revenue: by Geography 2019
    • Figure 21. Danaher Corporation (United States) Revenue, Net Income and Gross profit
    • Figure 22. Danaher Corporation (United States) Revenue: by Geography 2019
    • Figure 23. Thermo-Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
    • Figure 24. Thermo-Fisher Scientific Inc. (United States) Revenue: by Geography 2019
    • Figure 25. Merck KGaA (Germany) Revenue, Net Income and Gross profit
    • Figure 26. Merck KGaA (Germany) Revenue: by Geography 2019
    • Figure 27. Becton, Dickinson, and Company (United States) Revenue, Net Income and Gross profit
    • Figure 28. Becton, Dickinson, and Company (United States) Revenue: by Geography 2019
    • Figure 29. Hologic, Inc. (United States) Revenue, Net Income and Gross profit
    • Figure 30. Hologic, Inc. (United States) Revenue: by Geography 2019
    • Figure 31. Alere Inc. (United States) Revenue, Net Income and Gross profit
    • Figure 32. Alere Inc. (United States) Revenue: by Geography 2019
    • Figure 33. Bio-Rad Laboratories (United States) Revenue, Net Income and Gross profit
    • Figure 34. Bio-Rad Laboratories (United States) Revenue: by Geography 2019
    • Figure 35. Global Dignostics Rapid Test Kits: by Type USD Million (2020-2025)
    • Figure 36. Global Dignostics Rapid Test Kits: by Application USD Million (2020-2025)
    • Figure 37. Global Dignostics Rapid Test Kits: by End-Use USD Million (2020-2025)
    • Figure 38. Global Dignostics Rapid Test Kits: by Type K Units (2020-2025)
    • Figure 39. Global Dignostics Rapid Test Kits: by Application K Units (2020-2025)
    • Figure 40. Global Dignostics Rapid Test Kits: by End-Use K Units (2020-2025)
    • Figure 41. Global Dignostics Rapid Test Kits: by Type USD/Units (2020-2025)
    Some of the key companies/manufacturers profiled in the report
    • Siemens AG (Germany)
    • Roche Diagnostics (Switzerland)
    • Abbott Laboratories (United States)
    • Danaher Corporation (United States)
    • Thermo-Fisher Scientific Inc. (United States)
    • Merck KGaA (Germany)
    • Becton, Dickinson, and Company (United States)
    • Hologic, Inc. (United States)
    • Alere Inc. (United States)
    • Bio-Rad Laboratories (United States)
    Additional players considered in the study are as follows:
    bioMérieux (France) , BD (United States) , , ,
    Select License Type
    Sample Report Enquiry Before Buy Request Discount

    Speak with Analyst

    Want to find out more about this report?

    Get Free Consultation